SYLKE® launches Global Relief: Charitable Use Program
Our charitable use program that partners with nonprofits and frontline healthcare teams to deliver SYLKE® Adhesive Wound Closure dressings where th...
News
Popular Stories
-
-
SYLKE® is now ISO 13485:2016–certified and MDSAP-audited
SYLKE® Adhesive Wound Closure is now ISO 13485:2016–certified and MDSAP-audited - supporting market access, pending regulatory approval, in the Uni...
-
$10.03 Million Series A
In March 2025, SYLKE® raised a $10.03 million Series A at a $150 million pre-money valuation.
-
$5.50 Million Series Seed
In August 2024, SYLKE® raised a $5.5 million Series Seed at a $50 million pre-money valuation.
